Erica Daniels Archives - Green Market Report

StaffDecember 17, 2020
0-5-scaled.jpeg?fit=1200%2C365&ssl=1

3min8060

Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF), a leader in cannabis research and the development of clinically validated cannabis medicines, just announced its newest licensing agreement for its HOPE™ line of products, Zelira’s top-selling treatment developed for autism patients. Under the agreement with Alternative Solutions, a licensed grower, manufacturer and distributor of medical cannabis products in the District of Columbia (Washington DC), HOPE™ will be produced and distributed throughout the legal DC medical cannabis market beginning in Q2 2021.

“We are thrilled to have Alternative Solutions as a partner to launch HOPE™ in the nation’s capital,” says Dr. Oludare Odumosu, CEO & Managing Director USA for Zelira. “They are a leader in the DC medical cannabis market, and this partnership will allow legal access of HOPE™ to more patients across the country than ever before.”

Odumosu notes that this agreement with Alternative Solutions signifies HOPE’s largest expansion to date; because Washington DC has reciprocity with 32 other states in the US with approved medical cannabis programs, patients registered in those states are able to legally purchase medical cannabis products at an approved dispensary in Washington DC.

HOPE™ was formulated by Zelira Therapeutics and is the brainchild of Erica Daniels, founder of Hope Grows for Autism, a nonprofit aimed at improving the lives of families affected by autism through research, education and advocacy of medical marijuana. HOPE™ is currently available in the United States in Pennsylvania, through an exclusive license agreement with Ilera Healthcare, and in Louisiana, through an agreement with Advanced Biomedics LLC.


StaffOctober 30, 2020
shutterstock_1012237351-scaled.jpg?fit=1200%2C800&ssl=1

3min9920

Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF) just announced that its proprietary cannabinoid medicines, HOPE 1 and HOPE 2are now available by prescription to patients in Australia. The HOPE™ forumations, developed by Zelira and noted autism advocate Erica Daniels, first launched in 2019 in Pennsylvania and this fall in Louisiana. 

“We have had great success with HOPE™ in the US and are thrilled to be able to offer it to patients as a treatment option through the Therapeutic Goods Administration’s (TGA) Special Access Scheme,” says Osagie Imosogie, Chairman of Zelira Therapuetics. “Zelira is proud of this latest achievement in our mission to bring cannabinoid medicine to patients around the world.”

The HOPE cannabinoid medicines were developed to support the needs of patients with Autism Spectrum Disorder (ASD) by Daniels and Zelira Therapeutics, which then licensed the proprietary formulas to Ilera Healthcare in Pennsylvania and Ilera Holistic Healthcare in Louisiana. HOPE has since established itself as one of the top selling formulated medicinal cannabis products in Ilera Healthcare’s portfolio. 

“Autism families are finally beginning to have access to a truly better alternative than the harsh pharmaceuticals of the past and I am so proud that HOPE is now available in Australia,” says Erica Daniels, founder of Hope Grows for Autism and co-creator of the HOPE forumalations. “What started off as a labor of love to find a way to treat my own son is now helping parents around the world.” 

HOPE is part of Zelira’s family of revenue generating medicinal cannabis formulations. The products consist of two pharmaceutical-grade proprietary formulations developed as pharmaceutical-grade products targeting Autism Spectrum Disorder (ASD) as a disease indication. 

“Following the success of the HOPE™ launches in Pennsylvania and Louisiana, we are excited to make these products available to patients and physicians in Australia,” says Dr. Richard Hopkins, Zelira’s global Managing Director. “This represents another key milestone in our commitment to bring the benefits of HOPE to patients in global markets.”


StaffOctober 1, 2020
zelira.jpg?fit=850%2C531&ssl=1

5min10291

Launches First-in-the-State Medical Cannabis Product 

Scientifically Formulated for Autism Patients of All Ages

NEW ORLEANS (LA) October 1, 2020 /AxisWire/ Louisiana-based Ilera Holistic Healthcare is pleased to announce the statewide launch of the HOPE™ line of medical cannabis tinctures based on groundbreaking scientific research on using cannabis to treat the symptoms of autism spectrum disorder (ASD) in both children and adults.

Grown, cultivated, processed and packaged in Louisiana through a partnership between Ilera Holistic and Southern University’s Agricultural Center, HOPE™ products are available exclusively through state-licensed MMJ pharmacies and available to all Louisiana patients and families through a doctor’s prescription. 

“After seeing the success of HOPE™ in Pennsylvania, we were determined to bring it to patients of Louisiana, a state where we exceed the national percentage of autism diagnoses–while at-risk and under-served patients still struggle to receive safe and effective healthcare,” says Ilera Holistic CEO Dr. Chanda Macias. “Louisiana families deserve full access to all the benefits that cannabis medicine can provide, and we are thrilled to have HOPE in this market and available to everyone.”

Scientific research shows cannabis to be safe and effective on patients (including children) to treat ASD, and patients who use it have reported significant improvement in quality of life, mood, and sleep–and less reliance on other medications. 

HOPE™ is the brainchild of Erica Daniels, founder of Hope Grows for Autism, a nonprofit aimed at improving the lives of families affected by autism through research, education and advocacy of medical marijuana.

“The autism community in Louisiana is blessed to have a partner in Ilera Holistic Healthcare to bring HOPE to families affected by ASD,” says Daniels. “Now more than ever,  patients are struggling with the symptoms associated with autism. I am so thrilled that Ilera Holistic Healthcare is bringing HOPE to so many Louisiana patients who need it!”

“HOPE™ is another product with which we are proud to be associated,” said Janana Snowden, director of the Southern Institute for Medicinal Plants at the Southern University Agricultural Research and Extension Center. “The work we do aims to not only provide valuable research but to also provide potentially beneficial and accessible treatments for symptoms due to conditions that thousands of people live with daily, like autism.”

HOPE™ was formulated by Zelira Therapeutics, a leading global therapeutic medical cannabis company with access to the world’s largest and fastest growing cannabis markets. The company’s focus is on developing branded cannabis products for the treatment of a variety of medical conditions including insomnia, autism and chronic non-cancer pain.

HOPE™ is gluten, dairy, soy and nut-free; scientifically formulated, lab tested, and pesticide free; and only available in the state of Louisiana at licensed cannabis pharmacies. HOPE™ will be available in two formulations: “HOPE1,” a 1:1 THC:CBD tincture, and “HOPE2”, a 5:1 THC:CBD tincture. 

About Ilera Holistic Healthcare 

Ilera Holistic Healthcare is a fully integrated medical marijuana company that fuses science and innovation to discover life-changing therapies. In Louisiana, we partner our world-class cultivation and extraction methods with Southern University’s to expertly create and deliver consistent, high quality medicines. From seed and soil to dispensary shelves, Ilera is committed to providing a superior health and wellness experience. 

 

###

 


StaffMarch 6, 2020
Untitled-design-40.png?fit=960%2C640&ssl=1

11min1461624

In honor of International Women’s Day, we are releasing our annual “Most Important Women in Weed” list for 2020. This list includes women in the industry that have collectively moved the industry forward with all of their hard work, continuous dedication and effort.

This year we opened up the list for nominations and received almost a thousand nominees. After consideration of each, we have developed what we feel is one of the most inclusive and carefully curated lists of the most accomplished and impressive women in the cannabis industry.

As we could not name them all, we would like to thank and celebrate all of the women who have dedicated their precious time to the advancement of cannabis globally.

It is because of each one of these ladies that this industry remains in the lead above all others as far as female leadership is concerned.

This list is in no special order. Each one of these women provide a great contribution to the cannabis industry in their own unique and badass way.

Thank you to every one of you for all that you do!

The “List”

Dr. Chanda Macias

Yvonne DeLaRosa Green

Mara Gordon

Rosie Mattio

Shawna McGregor

Lori Ferrara

Gaynell Rogers

Stormy Simon

Trista Okel 

Lori Ajax

Amy Dawn Bourlon-Hilterbran

Kim Rivers

Amanda Soens

Dona Frank

Kat King

Sara Payan

Hannah Daphna

Sandra Castaneda

Erin Gore

Wendy Kornberg

Kristin Nevedal

Wendy Turner

Parisa Rad

Brittany Nicholson

Emily Paxhia

Jessica Billingsley 

Gia Moron

Andrea Brooks

Tahira Rehmatullah

Tracey Mason

Lindy Snyder

Jasmine Rose Gunderson

Shannon Hattan

Adelia Carrillo

Karen Petersen

Wanda James

Barbara Blaser

Ophelia Chong

Amanda Ostrowitz

Pamela Nicole Epstein

Melissa Mentele

Jamie Cooper

Sarah Remesch

Jessie Gill

Erica Daniels

Lizzy Jeff

Lelehnia DuBois

Whitney Beatty

Dr. Michele Ross

Manndie Tingler

Chef Lauren Gockley

Kyra Reed

Jamie Evans

Kristin Jordan

Ellie Siegel 

Sara Brittany Somerset

Linda Marsicano

Heidi Groshelle

Amber Senter

Nique Pichette

Jennifer Price

Molly Peckler 

Bonita Money

Susan Hwang

Judy Yee

Julie Chiarello

Leah Heis

Leslie Andrachuk

Terra Carver

Nancy Whiteman

Luna Stower

Karen Paull and Wendy Robbins

Beth Stavola

Alison Gordon

Penny Green

Sara Gullickson

Dr. Lakisha Jenkins

Pamela Hadfield

Jessica Peters

Dr. Rachel Knox and Dr. Jessica Knox

Tiffany Bowden

Mary Jane Gibson

Michelle Janikian

Dr. Uma Dhanabalan

Taylor Blake

AC Braddock

Kerri Accardi

Heather Sobel

Betty Aldworth

Cathy Jordan

Suzanne Sisley

Nina Parks

Eliza Nova Maroney

Selena Xochitl Martinez

Angelika Penuela-Ruiz

Sarah Mitra Payan

Gretchen Gailey

Nikki Lastreto

Ann Lawrence

Sheena Shiravi

Christina Ianuzzi

Kassandra Frederique

Shannon Buyers

Celia Tapp

Kelly Archer

Katie Field

Randi Sether

Shannon Reed

Katrina Yolen

Ngiste Abebe

Brooke Westlake

Courtney Maltais

Katrina Tso

Anne Don0hoe

Alicia Rose Kelley

Dr. Jacqueline Harding, PhD 

Mary Pryor 

Dr. Uma Dhabalan

Olivia Mannix

Heather DeRose

Libby Cooper

Leslie Hoffman

Yvonne Perez Emerson

 

Again, thank you to all of the women who do so much in our industry day in and day out. Your work does not go unnoticed and is deeply appreciated.

Happy International Women’s Day to all women around the world!

Special shout out to our Green Market Report co-founders Debra Borchardt and Cynthia Salarizadeh on this day!


Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Back to Top